少妇高潮大叫,三级视频一区,日韩在线黄,真紧h嘶爽老子h男人味,一本久久精品一区二区,欧美美女被日,小早川玲子1080绝顶狂,动漫美女被吸乳jk白丝91

^{<dl id="ilis8"></dl>}<strike id="ilis8"><option id="ilis8"></option></strike>

<blockquote id="ilis8"></blockquote>

產(chǎn)品基本信息

產(chǎn)品編號(hào)：C183473

產(chǎn)品名稱：7(R)-epi Carfilzomib (2S,4R)-diol

產(chǎn)品CAS：

規(guī)格含量：2.5mg

產(chǎn)品價(jià)格：面議

聯(lián)系我們:

產(chǎn)品詳細(xì)介紹

標(biāo)準(zhǔn)品編號(hào):	C183473
名稱:	7(R)-epi Carfilzomib (2S,4R)-diol
別名:	Carfilzomib Impurity 3; (S)-N-((R)-1-(((2S,4R)-1,2-Dihydroxy-2,6-dimethyl-3-oxoheptan-4-yl)amino)-1-oxo-3-phenylpropan-2-yl)-4-methyl-2-((S)-2-(2-morpholinoacetamido)-4-phenylbutanamido)pentanamide;
參考CAS:	868540-17-4
分子式:	C??H??N?O?
分子量:	737.93
類別:	Standards; Enzyme Activators and Inhibitors; Pharmaceutical/API Drug Impurities/Metabolites;
應(yīng)用:	Carfilzomib (2S,4R)-Diol is an impurity of Carfilzomib (C183460). Carfilzomib is a second-generation proteasome inhibitor that is used as a treatment in relapsed and refractory multiple myeloma.
參考文獻(xiàn)	Fostier, K., et al.: Oncotargets. Therap., 5, 237 (2012); Geurink, P.P., et al.: J. Med. Chem., 56, 1262 (2013); McCormack, P.L., et al.: Drugs., 72, 2023 (2012);

聯(lián)系我們

^{<dl id="ilis8"></dl>}<strike id="ilis8"><option id="ilis8"></option></strike>

<blockquote id="ilis8"></blockquote>